Integrating Metabolomics and Network Analyses to Explore Mechanisms of Geum japonicum var. chinense Against Pulmonary Fibrosis: Involvement of Arachidonic Acid Metabolic Pathway
Junyan Ran,
No information about this author
Qian Wang,
No information about this author
Tao Lu
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(4), P. 1462 - 1462
Published: Feb. 10, 2025
Pulmonary
fibrosis
(PF)
emerges
as
a
significant
pulmonary
sequelae
in
the
convalescent
phase
of
coronavirus
disease
2019
(COVID-19),
with
current
strategies
neither
specifically
preventive
nor
therapeutic.
Geum
japonicum
var.
chinense
(GJC)
is
used
traditional
Chinese
medicine
to
effectively
treat
various
respiratory
conditions.
However,
protective
effects
GJC
against
PF
remains
unclear.
In
present
study,
anti-PF
effect
aqueous
extract
was
studied
using
mouse
model
induced
by
bleomycin
(BLM).
To
characterize
metabolite
changes
related
and
reveal
therapeutic
targets
for
extract,
we
performed
metabolomic
network
analysis
on
mice
lungs.
Finally,
key
were
then
validated
Western
blotting.
alleviated
onset
progression
lung
inhibiting
inflammatory
responses
regulating
oxidative
stress
levels.
Integrating
serum
metabolomics
analyses
showed
arachidonic
acid
(AA)
pathway
be
most
important
metabolic
PF.
Further
validation
AA
protein
levels
rise
ALOX5,
PTGS2,
CYP2C9,
PLA2G2A
treatment
regulated
above
programming.
conclusion,
promising
botanical
drug
delay
mice.
The
primary
mechanism
action
associated
comprehensive
regulation
metabolites
expression
pathway.
Language: Английский
Health benefits of medicinal plant natural products via microbiota-mediated different gut axes
Xiang Li,
No information about this author
Yufan Liu,
No information about this author
Ning Liu
No information about this author
et al.
Pharmacological Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107730 - 107730
Published: April 1, 2025
This
review
examines
the
multifaceted
roles
of
medicinal
plant
natural
products
in
influencing
gut
microbiota
and
their
subsequent
impact
on
various
organ
systems
through
established
axes,
including
gut-brain,
gut-liver,
gut-heart,
gut-lung,
gut-kidney
axes.
Medicinal
have
exhibited
diverse
pharmacological
activities,
modulation
composition,
enhancement
metabolic
processes,
alleviation
inflammation
oxidative
stress.
Evidence
suggests
that
these
components
can
ameliorate
conditions
such
as
neurological
disorders,
syndrome,
chronic
kidney
disease
by
restoring
microbial
balance
improving
barrier
integrity.
Furthermore,
highlights
potential
to
foster
beneficial
communities
improve
health,
which
may
lead
reduced
severity
inflammation.
By
comprehensively
analyzing
current
literature,
this
provides
a
foundation
for
future
research
aim
at
exploring
therapeutic
applications
prevention
treatment.
The
findings
underscore
need
further
studies
elucidate
underlying
mechanisms
action
validate
clinical
efficacy
managing
modulation.
Language: Английский